Matches in Wikidata for { <http://www.wikidata.org/entity/Q95303821> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q95303821 description "article scientifique publié en 2020" @default.
- Q95303821 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95303821 description "scientific article published on 20 May 2020" @default.
- Q95303821 description "wetenschappelijk artikel" @default.
- Q95303821 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95303821 name "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 name "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 type Item @default.
- Q95303821 label "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 label "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 prefLabel "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 prefLabel "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 P1433 Q95303821-7C139399-340E-43D0-AFCA-49E9BF83E949 @default.
- Q95303821 P1476 Q95303821-2F5B1A57-F190-4476-8880-5D670D42F01E @default.
- Q95303821 P2093 Q95303821-0782C495-D7F9-43D0-902D-CB5EFC7D9131 @default.
- Q95303821 P2093 Q95303821-267F6715-0C1E-485A-A527-354C55E98D0A @default.
- Q95303821 P2093 Q95303821-3CD09AED-F01F-4BC6-BCC9-62AB16C3A10C @default.
- Q95303821 P2093 Q95303821-3D020C2D-CC53-4DCB-828E-867F3720DB06 @default.
- Q95303821 P2093 Q95303821-59975F03-B5D5-4763-83A8-E6C1B7D18610 @default.
- Q95303821 P2093 Q95303821-7433E990-813D-4640-AC0A-374786C9D560 @default.
- Q95303821 P2093 Q95303821-812CB20B-3824-48B8-8F69-9C9A003217C7 @default.
- Q95303821 P2093 Q95303821-B5B5786E-40B3-4D1E-B21F-C19D0F436B1B @default.
- Q95303821 P2093 Q95303821-D4FE03A6-65BF-4CF1-B239-2D9CE01E7A40 @default.
- Q95303821 P2093 Q95303821-E6CEE8AB-5F73-4671-92F3-08335E931FF2 @default.
- Q95303821 P2093 Q95303821-E870B18A-AA82-40AA-AF3A-54A06DC47371 @default.
- Q95303821 P31 Q95303821-5867CF38-C1B5-458A-B7A0-514FD0701787 @default.
- Q95303821 P356 Q95303821-5F634DD2-E13B-4A54-B094-FB62D2AC3DD4 @default.
- Q95303821 P50 Q95303821-D17E75C1-C29D-404D-ACC7-ABD149EB4D6F @default.
- Q95303821 P577 Q95303821-0AE4023C-2222-49A4-9B04-81E39E140FB5 @default.
- Q95303821 P698 Q95303821-AEB1B3F4-301B-4460-84CD-1DDFBADC569A @default.
- Q95303821 P921 Q95303821-38545A74-3B14-4508-9E15-34341A5CAE69 @default.
- Q95303821 P921 Q95303821-5D5EB8C5-A65A-474C-A8CF-B424E2B0A4C8 @default.
- Q95303821 P921 Q95303821-D230D9D1-9825-428D-85B2-BA174C9BBFC0 @default.
- Q95303821 P932 Q95303821-75FA63B8-1D5B-44E7-B187-49E104189CE9 @default.
- Q95303821 P356 ART.41315 @default.
- Q95303821 P698 32432388 @default.
- Q95303821 P1433 Q4797636 @default.
- Q95303821 P1476 "Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial" @default.
- Q95303821 P2093 "Anita DiFrancesco" @default.
- Q95303821 P2093 "Christopher J Swearingen" @default.
- Q95303821 P2093 "Daniel Clauw" @default.
- Q95303821 P2093 "Ismail Simsek" @default.
- Q95303821 P2093 "Jeyanesh Tambiah" @default.
- Q95303821 P2093 "John Bergfeld" @default.
- Q95303821 P2093 "Marc C Hochberg" @default.
- Q95303821 P2093 "Morgan Jones" @default.
- Q95303821 P2093 "Nancy E Lane" @default.
- Q95303821 P2093 "Timothy E McAlindon" @default.
- Q95303821 P2093 "Yusuf Yazici" @default.
- Q95303821 P31 Q13442814 @default.
- Q95303821 P356 "10.1002/ART.41315" @default.
- Q95303821 P50 Q95303813 @default.
- Q95303821 P577 "2020-05-20T00:00:00Z" @default.
- Q95303821 P698 "32432388" @default.
- Q95303821 P921 Q1777118 @default.
- Q95303821 P921 Q42824440 @default.
- Q95303821 P921 Q62736 @default.
- Q95303821 P932 "7589351" @default.